An exploratory clinical study on the effects of SGLT2 inhibitors for type 2 diabetes (T2DM) patients with sleep apnea (SA)
Not Applicable
Recruiting
- Conditions
- sleep apnea
- Registration Number
- JPRN-UMIN000031793
- Lead Sponsor
- Juntendo University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with moderate renal disease (eGFR<30 ml/min) patients with ketosis and diabetic coma patients with severe infection, perioperative period and severe trauma patients with poor control DM
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in apnea-hypopnea index (AHI), body weight, body composition, and HbA1c, as well as the levels of microalbuminuria and urine L-FABP
- Secondary Outcome Measures
Name Time Method